Undoubtedly, Mesomark is a breakthrough in mesothelioma detection. Mesothelioma is lethal form of cancer because of its highest aggressive nature as well as inability to diagnose at earlier stages. In most of the case, the diagnosis of disease occur, when the disease have reached stage 3 or 5. At that time the treatment options are restricted to palliative than curative. Now, a latest mesomark blood test for mesothelioma is available for the earlier diagnosis of disease. This earlier diagnosis results in better cure of the patient.
The mesomark blood test for mesothelioma is developed by Fujirebio Diagnostics Inc. of Malvern, Pennsylvania which is a leader in the field of oncology and its testing. This test actually measures the amount of a mesothelioma biomarker in human serum.
Procedure of Mesothelioma Test
Mesomark blood test for mesothelioma can be easily performed. It uses an enzyme-linked immunosorbent assay technique to measure the amount of Soluble Mesothelin-Related Peptides (SMRP) in patients’ serum. The SMRP is a biomarker in mesothelioma and is produced by mesotheliomal cells. They are found in elevated amount in the serum of cancer patients. The detection of SMRP through a mesomark helps in early diagnosis and better prognosis of patients.
Mesomark blood test for mesothelioma is an in-vitro test. The blood sample of patient is sent to the laboratory for chemical analysis. It does not only help in diagnosis but also to monitor the success of treatments in patients with mesothelioma.